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1. Introduction 
At the end of pregnancy, the umbilical cord com- 
prises two thick-walled arteries and one vein, deeply 
embedded in Wharton’s jelly. The latter contains large 
amounts of glycosaminoglycans (GAG) and collagen; 
it probably represents the fused adventitial layers of 
the three large vessels [ 11. 
Thus, this organ may be considered as a vascular 
tissue, but also presents some foetal characteristics. 
These two latter types of tissues have been the object 
of relatively few metabolic studies in the human spe- 
cies, owing to obvious ethical reasons. Therefore, in- 
vestigations on the umbilical cord, which is at the 
same tin-,e vascular and foetal, might provide more 
insights into the physiology and biochemistry of such 
structures, and furthermore it is easily available. 
We have followed the fate of [U-14C]glucose into 
umbilical cord slices, recovering radioactivity from 
the GAG, glycogen, proteins, lipds and CO,. 
Significant amounts of 14C could be recovered 
from these various fractions, thereby indicating a 
rather large diversification of glucose metabolism in 
this tissue. 
Furthermore, the effect of insulin at a supramaxi- 
ma1 concentration was also tested. It could be shown 
that the effects of this hormone are most prominent 
when glucose concentrations in the incubation medi- 
um are in a physiological range, and less so at higher 
glucose levels. 
2. Material and methods 
The umbilical cords were freed of contaminating 
blood and sliced as previously described [2]. Batches 
of 8 slices (ca. 1 g) were incubated in 10 ml Krebs- 
Ringer phosphate buffer [3] containing 5 or 20 mM 
glucose (or none in the controls). A similar series of 
flasks contained also 1000 pU/ml of crystalline insu- 
lin/ml. 
Lipids were extracted from all the slices according 
to Folch et al. [4]. 
Glycogen was extracted from 2 defatted slices by 
the technique of Le Barron [S], and reprecipitated 
thrice. 
For GAG, four slices and l/2 of the incubation me- 
dium were digested overnight at pH 1.5 with Pepsin 
(Merck, Darmstadt, W. Germany), followed by a 2 hr 
step with trypsin at pH 8.5 (same dealer). They were 
precipitated with cetylpyrridinium chloride (CPC) ac- 
cording to Scott [6]. 
Both glycogen and GAG were dissolved in a few 
drops of 5 M HCl at 90” until the solution was clear. 
It was then brought to 2 ml with distilled water and 
to 15 ml with Insta-Gel (Packard, Benelux). 
Proteins were precipitated from 2 slices and 1/4th 
of the medium with trichloroacetic acid (TCA), and 
further washed several times with the same solution. 
The “classical” hydrolytic step (15 min at 90”) was 
avoided, as it solubilized a large amount of collagen, 
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Table 1 
Recovery of radioactivity from [ U-‘4C]glucose into various fractions of the human umbilical cord (in nmoles glucose/g wet 
weight/3 hr). 
Glucose 5 mM 
Insulin: 0 pU/ml Insulin: 1000 pU/ml Difference P 
co2 14.10 + 0.90 15.30 * 0.92 +1.20 N.S. 
Glycogen 28.9 + 3.3 37.5 * 2.0 +8.6 P < 0.05 
Glycosaminoglycans 69.0 k 8.1 118.8 f 12.8 +49.8 P < 0.01 
Lipids 7.5 2 0.4 6.9 f. 0.9 -0.6 N.S. 
Proteins 48.8 * 4.6 62.2 + 4.8 +13.4 P < 0.05 
Glucose 20 mM 
co2 45.6i: 1.21 46.2 k 1.40 +0.6 N.S. 
Glycogen 88.5 f 5.5 99.9 f 5.0 +11.4 N.S. 
Glycosaminoglycans 199.4 2 29.1 305.5 * 30.5 +106.1 P < 0.01 
Lipids 20.1 * 1.2 21.7 * 1.4 +1.6 N.S. 
Proteins 150.6 t 19.5 162.2 + 20.0 +11.6 N.S. 
14 cords were incubated in bicarbonate buffer with 0.1 PCi of labelled glucose/ml, with or without insulin. Values are means + 
SEM. N.S. : non significant. 
even in this short lapse of time. The precipitate was 
dissolved in Soluene- 100 (Packard, Benelux), and 
counted in Insta-Gel (total volume: 15 ml). 
Labelled CO2 was determined separately in a stan- 
dard Warburg apparatus. The contents of the central 
well (including the filter paper wick) were transfer- 
. red quantitatively in scintillation counting vials with 
15 in1 Insta-Gel. 
All counting procedures were performed in a Nu- 
clear Mark I scintillation counter, internal standards 
were used for quenching corrections. 
3. Results and conclusions 
The results are presented in table 1, from which it 
is evident that the pathways studied are mainly con- 
trolled by the levels of glucose in the incubating me- 
dium. 
The recovery of radioactivity in glycogen could al- 
so be expected, since electron microscopy reveals 
numerous glycogen clusters in the cells of Wharton’s 
jelly [9]. However, its mere presence does not imply 
an active synthesis: it has been shown that the placenta 
contains large amounts of glycogen, but has lost at 
term the glycogenic potentialities it had earlier in preg- 
nancy [lo]. 
The CO, output is low, and is not influenced by 
insulin; but these experiments were conducted in 
phosphate buffer, which is well known to mask some 
insulinic effect [ 71. 
Lipids are also labelled from [U-14C]glucose. This 
fact is also consistent with the presence of sparce lipid 
droplets in the cells of the jelly [9]. AlthougJz the rate 
of incorporation is low, it surely warrants further frac- 
tionation and dynamic studies: indeed the easily avail- 
able umbilical cord might then prove a useful tool in 
the study of atherosclerosis and other angiopathies. 
The more active of the metabolic routes tested is All of the metabolic pathways studied are enhanced 
the incorporation of radioactivity from glucose into 
the GAG fraction. This was not surprising, since the 
by insulin, excepted CO2 (already discussed) and lip- 
ids, when the surrounding glucose concentrations are 
GAG represent nearly 10% of the dry weight [8] of 
the cord tissue; but surprisingly enough, the biosyn- 
in the “normal” range. By contrast, when exogenous 
glucose levels are higher, insulin loses its significant 
thesis of these compounds had never been studied here- 
tofore in the umbilical cord, although the latter is the 
major source of commercial hyaluronic acid. Such a 
high rate of synthesis, if sustained during the whole 
pregnancy, would lead to the accumulation of about 
twice the amounts of GAG present in the tissue at 
term [8]. This finding suggests that the turnover rate 
of these polymers must at best be very slow. 
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effects excepted for the biosynthesis of GAG. 
It is well known that the umbilical cords of diabet- 
ic pregnancies are usually grossly oedematous, and 
contain an excess of hexosamines [ 111, which reflects 
an overproduction of GAG with their high water-bind- 
ing capacity. The maternal hyperglycaemia, partially 
transmitted to the foetal blood, might account for 
this fact. However, this hyperglycaemia can induce a 
foetal insulinic response, which might potentiate its 
effects on GAG oversynthesis. Although it is doubful 
that foetal insulin ever reaches levels sufficient to ex- 
ert such an action, we cannot definitely rule out this 
hypothesis at present. 
One pitfall in the present study is that the cord 
tissue evidently lacks an adult homologue as a control. 
Even aorta cannot be a safe reference tissue, since 
both the site of sampling [ 121, as well as ageing [ 131 
modify its metabolic profile. Furthermore, the ex- 
perimental conditions vary according with the authors, 
who do not express their data in similar units. Thus 
any comparison with those results can only lead to 
very rough estimates. 
Nonetheless, the glucose metabolism by the umbil- 
ical cord tissue seems much more active and diversi- 
fied than in aortic tissue. Such a finding, together with 
a low citric acid cycle activity [ 141, and a very active 
aerobic glycolysis [2], suggest hat the cord tissue at 
term has retained at least a large part of its foetal 
metabolic potentialities. 
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